Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
复制标题
DOI:
10.1007/s10620-021-07321-7
复制
发表时间:
2022-09
影响因子:
3.1
通讯作者:
Mahmud, Nadim
中科院分区:
文献类型:
--
作者:
Panchal, Sarjukumar A.;Kaplan, David E.;Goldberg, David S.;Mahmud, Nadim
Alcoholic hepatitis (AH) is a clinically diagnosed syndrome with high short-term mortality for which liver transplantation may be curative. A lack of validated algorithms to identify AH hospitalizations has hindered clinical epidemiology research. This was a retrospective cohort study of patients with cirrhosis using Veterans Health Administration (VHA) data from 2008 to 2015. We randomly sampled hospitalizations based upon abnormal liver tests and administrative codes for acute hepatitis or alcohol-associated liver disease (ALD). Hospitalizations were manually adjudicated for AH per society guidelines. A priori algorithms were evaluated to compute positive predicted value (PPV) and positive likelihood ratio (LR+), and were tested in an external University of Pennsylvania Health System (UPHS) cohort. Of 368 hospitalizations, 142 (38.6%) were adjudicated as AH. AH patients were younger (55 vs. 58 years, p < 0.001), less likely to have prior cirrhosis decompensation (57% vs. 73.9%, p < 0.001), and had higher AST-to-ALT ratios (median 2.9 vs. 1.9 mg/dL, p < 0.001) and higher bilirubin levels (median 2.9 vs. 1.9 mg/dL, p < 0.001). Algorithms combining clinical laboratory criteria (AST > 85 U/L but < 450 U/L, AST-to-ALT ratio > 2, total bilirubin > 5 mg/dL) and administrative coding criteria yielded the highest PPV (96.4%, 95% CI 87.7–99.6) and the highest LR+ (43.0, 95% CI 10.6–173.5). Several algorithms demonstrated 100% PPV for definite AH in the UPHS external cohort. We have identified algorithms for AH hospitalizations with excellent PPV and LR+. These high-specificity algorithms may be used in VHA datasets to identify patients with high likelihood of AH, but should not be used to study AH incidence.
登录
查看更多内容
DOI:
10.1016/j.cgh.2017.11.045
发表时间:
2018-08
期刊:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
影响因子:
--
作者:
Cholankeril G;Ahmed A
通讯作者:
Ahmed A
DOI:
10.1002/hep.31558
发表时间:
2021-01
期刊:
Hepatology (Baltimore, Md.)
影响因子:
--
作者:
Mahmud N;Fricker Z;Hubbard RA;Ioannou GN;Lewis JD;Taddei TH;Rothstein KD;Serper M;Goldberg DS;Kaplan DE
通讯作者:
Kaplan DE
影响因子:
29.4
作者:
Beste, Lauren A.;Leipertz, Steven L.;Ioannou, George N.
通讯作者:
Ioannou, George N.
影响因子:
2.9
作者:
Jinjuvadia R;Liangpunsakul S;Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium
通讯作者:
Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium
DOI:
10.1016/j.cgh.2015.07.010
发表时间:
2015-12
期刊:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
影响因子:
--
作者:
Kaplan DE;Dai F;Aytaman A;Baytarian M;Fox R;Hunt K;Knott A;Pedrosa M;Pocha C;Mehta R;Duggal M;Skanderson M;Valderrama A;Taddei TH;VOCAL Study Group
通讯作者:
VOCAL Study Group